Ruprecht-Karls-Universität Heidelberg

Chronic hand eczema in Germany: 5-year follow-up data from the CARPE registry (2019) Apfelbacher CJ, Ofenloch RF, Weisshaar E, Molin S, Bauer A, Mahler V, Heinrich A, et al. Journal article Predictors for the Development of Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) - Data from the German SSc-Network (2019) Kreuter M, Bonella F, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al. Conference contribution Thirteen weeks of supplementation of vitamin D and leucine-enriched whey protein nutritional supplement attenuates chronic low-grade inflammation in sarcopenic older adults: the PROVIDE study (2019) Liberman K, Njemini R, Luiking Y, Forti LN, Verlaan S, Bauer JM, Memelink R, et al. Journal article High sensitivity and clonal stability of the genomic fusion as single marker for response monitoring in ETV6-RUNX1-positive acute lymphoblastic leukemia (2019) Hoffmann J, Krumbholz M, Gutiérrez HP, Fillies M, Szymansky A, Bleckmann K, zur Stadt U, et al. Journal article Therapy landscape in patients with metastatic HER2-positive breast cancer: Data from the PRAEGNANT real-world breast cancer registry (2019) Lux MP, Nabieva N, Hartkopf AD, Huober J, Volz B, Taran FA, Overkamp F, et al. Journal article Extending the time window for intravenous thrombolysis in acute ischemic stroke using magnetic resonance imaging-based patient selection (2019) Ringleb P, Bendszus M, Bluhmki E, Donnan G, Eschenfelder C, Fatar M, Kessler C, et al. Journal article Erratum: Use of negative pressure wound therapy with instillation and dwell time for wound Treatment - Results of an expert consensus conference [Erratum: Einsatz der Vakuuminstillationstherapie für die Wundbehandlung - Ergebnis einer Expertenkonsensuskonferenz] (2019) Horch RE, Braumann C, Dissemond J, Lehner B, Hirche C, Woeste G, Wozniak G, et al. Journal article, Erratum Heparin for prophylaxis of venous thromboembolism in intracerebral haemorrhage (2019) Sprügel M, Sembill J, Kuramatsu J, Gerner S, Hagen M, Röder S, Endres M, et al. Journal article Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab (2019) Eckstein M, Erben P, Kriegmair MC, Worst TS, Weiss CA, Wirtz RM, Wach S, et al. Journal article FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer (2019) Breyer J, Wirtz RM, Erben P, Rinaldetti S, Worst TS, Stoehr R, Eckstein M, et al. Journal article